NCT07562581 A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC Status NOT_YET_RECRUITING Phase PHASE2
NCT06993506 Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer Status RECRUITING Phase N/A
NCT06884839 Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis Status COMPLETED Phase N/A
NCT06863272 A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) Status RECRUITING Phase PHASE1/PHASE2
NCT06712745 Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung Status RECRUITING Phase EARLY_PHASE1
NCT05789589 Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases Status SUSPENDED Phase PHASE1/PHASE2
NCT04499365 68Ga-FAPI PET/CT in Patients With Various Types of Cancer Status RECRUITING Phase EARLY_PHASE1
NCT03652493 Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway Status COMPLETED Phase PHASE2
NCT03644303 Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients. Status COMPLETED Phase NA